<DOC>
	<DOCNO>NCT00751699</DOCNO>
	<brief_summary>This study evaluate pharmacokinetics 5-ASA N-Ac-5-ASA associate 3 regimen oral mesalamine 2.4 g/day ( Lialda 2.4 g/day 2 x 1.2 g every 24 hour , AsacolÂ® 6 x 400 mg every 24 hour , Asacol 2 x 400 mg every 8 hour ) . Primary endpoint 5-ASA area plasma concentration versus time curve zero 24 hour ( AUC24 ) total 5-ASA percent dose excrete ( A ' e [ % ] ) 24-hour period Day 7 .</brief_summary>
	<brief_title>Pharmacokinetics Asacol 2.4 g/Day Lialda 2.4 g/Day Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Males females 18 45 year age , inclusive , screen good general health base medical history , physical examination , laboratory evaluation ; If female , must ( document patient report medical history ) : postmenopausal ( least 1 year without spontaneous menses ) , surgically sterile ( tubal ligation hysterectomy ) , use acceptable contraception [ e.g. , sexual partner nonreversed vasectomy ( azoospermia 2 test ) , 2 barrier method ( e.g. , condom , diaphragm , spermicide ) , intrauterine device ] ; Body mass index ( BMI ) 18 32 kg/m2 , inclusive ; Able swallow assign study medication tablet whole ; , Able fulfill requirement protocol provide write informed consent . History presence condition gastrointestinal ( GI ) surgery cause malabsorption effect GI motility ; Any uncontrolled acute disease major surgical operation require hospitalization within 1 month screening ; History diabetes , syncope , cardiovascular , hepatic , renal disease ; Uncontrolled chronic disease hypertension , systemic lupus erythematosus , rheumatoid arthritis ; History cancer within last 5 year ( except basal cell carcinoma document 6month remission ) ; Any known enzymeinducer , enzymeinhibitor , report chronic exposure enzymeinducers paint solvent pesticide within 30 day treatment ; Any prescription drug herbal remedy within 14 day prior schedule dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>